Previous Close | 4.3000 |
Open | 2.9500 |
Bid | 0.0000 |
Ask | 4.8000 |
Strike | 75.00 |
Expire Date | 2024-09-20 |
Day's Range | 2.9500 - 4.3000 |
Contract Range | N/A |
Volume | |
Open Interest | 4 |
HYDERABAD, India, May 28, 2024--Dr. Reddy's Laboratories Ltd. today announced the appointment of Milan Kalawadia as Chief Executive Officer, North America.
HYDERABAD, India & REYKJAVIK, Iceland, May 21, 2024--Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva®.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.